Review of liver function, tumor markers and tumors after long-term topical use of 1% kojic acid cream

Hideo Nakayama, Tamotsu Ebihara, Hiroyuki Jinnai

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We have used kojic acid (KA) for clinical treatment of various facial pigmentary disorders such as liver spots (melasma), solar lentigo, nevus of Ota, ephelid and pigmented cosmetic dermatitis (PCD). To confirm the effectiveness and safety of long-term use of KA, we have followed 16 patients who had used 1% KA cream for an average 2 years and 8 months. The longest period of usage was 7 years and 11 months. Results of liver function tests, complete blood count and tumor markers, including alpha fetoprotein, did not reveal any abnormalities due to the use of KA. In addition to our findings, we found no reports of cancer production or induction of skin cancers due to the topical application of 1% KA creams. In conclusion, the topical whitener, kojic acid, can be used safely for various facial pigmentary disorders.

Original languageEnglish
Pages (from-to)412-415
Number of pages4
JournalNishinihon Journal of Dermatology
Volume67
Issue number4
DOIs
Publication statusPublished - 2005
Externally publishedYes

Fingerprint

Tumor Biomarkers
Liver
Neoplasms
Nevus of Ota
Lentigo
Melanosis
Blood Cell Count
Liver Function Tests
alpha-Fetoproteins
Skin Neoplasms
Dermatitis
Cosmetics
kojic acid
Safety

ASJC Scopus subject areas

  • Dermatology

Cite this

Review of liver function, tumor markers and tumors after long-term topical use of 1% kojic acid cream. / Nakayama, Hideo; Ebihara, Tamotsu; Jinnai, Hiroyuki.

In: Nishinihon Journal of Dermatology, Vol. 67, No. 4, 2005, p. 412-415.

Research output: Contribution to journalArticle

Nakayama, Hideo ; Ebihara, Tamotsu ; Jinnai, Hiroyuki. / Review of liver function, tumor markers and tumors after long-term topical use of 1% kojic acid cream. In: Nishinihon Journal of Dermatology. 2005 ; Vol. 67, No. 4. pp. 412-415.
@article{391ba1655f0242b18e38e67bcfc36899,
title = "Review of liver function, tumor markers and tumors after long-term topical use of 1{\%} kojic acid cream",
abstract = "We have used kojic acid (KA) for clinical treatment of various facial pigmentary disorders such as liver spots (melasma), solar lentigo, nevus of Ota, ephelid and pigmented cosmetic dermatitis (PCD). To confirm the effectiveness and safety of long-term use of KA, we have followed 16 patients who had used 1{\%} KA cream for an average 2 years and 8 months. The longest period of usage was 7 years and 11 months. Results of liver function tests, complete blood count and tumor markers, including alpha fetoprotein, did not reveal any abnormalities due to the use of KA. In addition to our findings, we found no reports of cancer production or induction of skin cancers due to the topical application of 1{\%} KA creams. In conclusion, the topical whitener, kojic acid, can be used safely for various facial pigmentary disorders.",
author = "Hideo Nakayama and Tamotsu Ebihara and Hiroyuki Jinnai",
year = "2005",
doi = "10.2336/nishinihonhifu.67.412",
language = "English",
volume = "67",
pages = "412--415",
journal = "Nishinihon Journal of Dermatology",
issn = "0386-9784",
publisher = "Kyushu University, Faculty of Science",
number = "4",

}

TY - JOUR

T1 - Review of liver function, tumor markers and tumors after long-term topical use of 1% kojic acid cream

AU - Nakayama, Hideo

AU - Ebihara, Tamotsu

AU - Jinnai, Hiroyuki

PY - 2005

Y1 - 2005

N2 - We have used kojic acid (KA) for clinical treatment of various facial pigmentary disorders such as liver spots (melasma), solar lentigo, nevus of Ota, ephelid and pigmented cosmetic dermatitis (PCD). To confirm the effectiveness and safety of long-term use of KA, we have followed 16 patients who had used 1% KA cream for an average 2 years and 8 months. The longest period of usage was 7 years and 11 months. Results of liver function tests, complete blood count and tumor markers, including alpha fetoprotein, did not reveal any abnormalities due to the use of KA. In addition to our findings, we found no reports of cancer production or induction of skin cancers due to the topical application of 1% KA creams. In conclusion, the topical whitener, kojic acid, can be used safely for various facial pigmentary disorders.

AB - We have used kojic acid (KA) for clinical treatment of various facial pigmentary disorders such as liver spots (melasma), solar lentigo, nevus of Ota, ephelid and pigmented cosmetic dermatitis (PCD). To confirm the effectiveness and safety of long-term use of KA, we have followed 16 patients who had used 1% KA cream for an average 2 years and 8 months. The longest period of usage was 7 years and 11 months. Results of liver function tests, complete blood count and tumor markers, including alpha fetoprotein, did not reveal any abnormalities due to the use of KA. In addition to our findings, we found no reports of cancer production or induction of skin cancers due to the topical application of 1% KA creams. In conclusion, the topical whitener, kojic acid, can be used safely for various facial pigmentary disorders.

UR - http://www.scopus.com/inward/record.url?scp=25144515525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25144515525&partnerID=8YFLogxK

U2 - 10.2336/nishinihonhifu.67.412

DO - 10.2336/nishinihonhifu.67.412

M3 - Article

AN - SCOPUS:25144515525

VL - 67

SP - 412

EP - 415

JO - Nishinihon Journal of Dermatology

JF - Nishinihon Journal of Dermatology

SN - 0386-9784

IS - 4

ER -